AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $111 | -68.4% | 12,166 | -75.2% | 0.00% | – |
| Q4 2022 | $351 | -100.0% | 49,096 | -66.1% | 0.00% | -100.0% |
| Q3 2022 | $726,000 | +109.2% | 144,957 | +1.7% | 0.00% | – |
| Q2 2022 | $347,000 | -65.2% | 142,577 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $998,000 | -21.6% | 146,142 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $1,273,000 | +121.8% | 157,637 | +168.7% | 0.00% | 0.0% |
| Q3 2021 | $574,000 | +144.3% | 58,672 | +67.8% | 0.00% | – |
| Q2 2021 | $235,000 | -25.6% | 34,970 | 0.0% | 0.00% | – |
| Q1 2021 | $316,000 | +58.8% | 34,970 | +17.1% | 0.00% | – |
| Q4 2020 | $199,000 | +4875.0% | 29,860 | +4876.7% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 600 | +50.0% | 0.00% | – |
| Q3 2017 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
| Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
| JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
| FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
| Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
| KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
| HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
| Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |